Internal Medicine, Nephrology · Enid, OK
NPI
1306949235
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
312 E Garriott Rd
Enid, OK, 73701
Phone (580) 233-0595
Groups this clinician bills Medicare through
Medicare paid, 2024
$463K
3,441 services
Medicare patients, 2024
880
Average age 75
Drug cost, 2024
$655K
2,555 prescriptions
Company payments, 2025
$74.01
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rashmi Vijayvargiya was code 99214 (office e&m - established), 1,145 times for 652 patients. In total Rashmi Vijayvargiya billed 3,441 services in 15 codes, and Medicare paid $463K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,145 | 652 | $86.59 | $99K |
| 99232 Hospital E&M - Subsequent | Facility | 634 | 109 | $58.43 | $37K |
| 90960 ESRD Related Services (not dialysis) | Office | 565 | 82 | $261.32 | $148K |
| 90966 ESRD Related Services (not dialysis) | Office | 278 | 37 | $206.81 | $57K |
| 90961 ESRD Related Services (not dialysis) | Office | 250 | 52 | $215.50 | $54K |
| 99204 Office E&M - New | Office | 196 | 196 | $110.46 | $22K |
| 99223 Hospital E&M - Initial | Facility | 163 | 119 | $128.48 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 80 | 38 | $87.84 | $7,027 |
| 99213 Office E&M - Established | Office | 50 | 49 | $60.60 | $3,030 |
| 99291 Critical Care E&M | Facility | 32 | 17 | $155.86 | $4,987 |
| 90962 ESRD Related Services (not dialysis) | Office | 22 | 17 | $147.91 | $3,254 |
| 90989 Peritoneal Dialysis | Office | 16 | 16 | $392.00 | $6,272 |
By year: 2022 $457K for 3,372 services; 2023 $420K for 3,016 services; 2024 $463K for 3,441 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rashmi Vijayvargiya prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 344 prescriptions and refills. In total Rashmi Vijayvargiya wrote 2,555 Medicare prescriptions that cost $655K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 344 | 382 | 54 | $215K |
| Sevelamer Carbonate Generic | 207 | 308 | 53 | $30K |
| Furosemide Generic | 139 | 248 | 43 | $644 |
| Potassium Chloride Generic | 126 | 222 | 34 | $2,572 |
| Calcitriol Generic | 116 | 239 | 34 | $933 |
| Hydralazine Hcl Generic | 94 | 181 | 26 | $1,386 |
| Amlodipine Besylate Generic | 88 | 223 | 27 | $728 |
| Ropinirole Hcl Generic | 76 | 146 | 22 | $663 |
| Allopurinol Generic | 62 | 119 | 13 | $421 |
| Lisinopril Generic | 59 | 110 | 14 | $375 |
| Metoprolol Tartrate Generic | 54 | 96 | 15 | $406 |
| Carvedilol Generic | 52 | 103 | 13 | $369 |
| Velphoro Sucroferric Oxyhydroxide | 52 | 68 | 18 | $133K |
| Pantoprazole Sodium Generic | 52 | 78 | Under 11 | $497 |
| Clonidine Hcl Generic | 46 | 66 | 12 | $145 |
Brand drugs: 618 claims; generic drugs: 1,918 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rashmi Vijayvargiya $74.01 ($74.01 in general payments such as food, travel and fees) from 1 company. The largest payer was Fresenius USA Marketing, Inc. with $74.01.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 4 | $74.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.